Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QA04 | ISIN: IL0011794802 | Ticker-Symbol:
NASDAQ
26.04.24
22:00 Uhr
10,880 US-Dollar
+0,170
+1,59 %
1-Jahres-Chart
CELLEBRITE DI LTD Chart 1 Jahr
5-Tage-Chart
CELLEBRITE DI LTD 5-Tage-Chart
GlobeNewswire (Europe)
300 Leser
Artikel bewerten:
(1)

Cellebrite DI Ltd: Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company's Case-to-Closure Platform

New SaaS delivery transforms access, collection and analysis of data from a wide variety of remote devices across the enterprise with unparalleled efficiency and consent-based security

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in Digital Investigative solutions, today unveils Cellebrite Endpoint Inspector SaaS. This enhanced delivery model of our industry-leading Endpoint Inspector product offers enterprise customers and eDiscovery service providers next-generation digital forensic capabilities that enable the streamlined collection and analysis of data from diverse remote devices, all within a unified, consent-based, secure framework.

With Cellebrite's evolving suite of SaaS solutions in its Case-to-Closure platform, organizations can now quickly deploy seamless, targeted remote data collection for faster acquisition of critical information, reducing time-to-data from days to minutes. This includes enabling examiners to retrieve Cloud messaging in cooperation with custodians. The solution complements Cellebrite's SaaS usage-based offering for mobile data collection in the private sector, Endpoint Mobile Now. As a top-tier provider for eDiscovery professionals, Endpoint Inspector SaaS offers organizations a centralized platform for real-time visibility into collection statuses. This efficiency eliminates the need for multiple tools or manual tracking in spreadsheets, while its automatic updates for new device software versions mitigate the risks tied to frequent device upgrades.

"With the rapid adoption of SaaS solutions, it's critical that our systems not only stay ahead of technological advancements but also adhere to the highest ethical and legal standards," says Ronnen Armon, Chief Products Technologies Officer at Cellebrite. "Cellebrite Endpoint Inspector SaaS is at the forefront of this, ensuring examiners can efficiently collect data from a range of devices, irrespective of location, without managing software or compromising on consent and security."

Cellebrite is dedicated to leading the industry not just in technological innovation but also in ethical practices. The Endpoint Inspector SaaS operates strictly within a consent-based framework, ensuring all activities are transparent and authorized by device owners. This approach is fundamental to our values and is embedded in every aspect of our solution.

For More Information:

Discover how Cellebrite Endpoint Inspector SaaS can transform your enterprise data collection and analysis. Visit us at https://enterprise.cellebrite.com/Cellebrite-endpoint-inspector/

About Cellebrite?
?
Cellebrite's, or follow us on X at @Cellebrite.

About Cellebrite Enterprise Solutions

In a world that's evolving rapidly, Cellebrite Enterprise Solutions looks beyond the horizon to design solutions to keep data within reach, transform it and reveal important insights to protect your business and employees. From headquarters to home office, eDiscovery professionals and corporate investigators can access endpoints anywhere with Cellebrite's enterprise solution offerings.

Media?
Victor Cooper?
Sr. Director of Corporate Communications + Content Operations?
Victor.cooper@cellebrite.com?
+1 404.804.5910?
?
Investor Relations?
Andrew Kramer?
Vice President, Investor Relations?
investors@cellebrite.com?
+1 973.206.7760?


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.